ARE BIOSIMILARS EQUIVALENT TO ORIGINATOR MOLECULES IN THE REAL-WORLD? ASSESSMENTS OF EFFICACY, TOXICITY, AND TOLERABILITY OF INFLIXIMABS IN INFLIXIMAB-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Edgerton, C. [1 ]
Adams, C. [1 ]
Frick, A. [2 ]
Helfgott, S. M. [3 ]
Huston, K. [4 ]
Milligan, S. [5 ]
Singh, J. A. [6 ]
Soloman, N. [7 ]
机构：
[1] Articularis Healthcare, Summerville, SC USA
[2] Trio Hlth Analyt, La Mirada, CA USA
[3] Brigham & Womens Hosp, Boston, MA USA
[4] Ctr Rheumat Dis Allergy Immunol, Kansas City, MO USA
[5] Trio Hlth Analyt, Louisville, CO USA
[6] Univ Alabama Birmingham, Birmingham, AL USA
[7] Arizona Arthrit, Phoenix, AZ USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO154
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [21] Incidence of Anti-Drug Antibodies in Rheumatoid Arthritis Patients Treated with Adalimumab, Etanercept, or Infliximab in a Real-World Setting
    Moots, R. J.
    Xavier, Ricardo
    Mok, Chi Chiu
    Rahman, Mahboob U.
    Tsai, Wen-Chan
    Al Maini, Mustafa
    Pavelka, Karel
    Mahgoub, Ehab
    Kotak, Sameer
    Korth-Bradley, Joan
    Pedersen, Ronald
    Mele, Linda
    Shen, Qi
    Vlahos, Bonnie
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [22] Comparing Real-world Retention Rates in a Matched Cohort of Rheumatoid Arthritis Patients Who Either Remained on the Etanercept Originator or Switched to a Biosimilar
    Baganz, Lisa
    Strangfeld, Anja
    Herzer, Peter
    Krause, Andreas
    Tony, Hans-Peter
    Zink, Angela
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [23] Efficacy of switching from originator etanercept to biosimilar YLB113 in real-world patients with rheumatoid arthritis: A retrospective 12 months follow-up study
    Sakane, Hideo
    Yonemoto, Yukio
    Okamura, Koichi
    Suto, Takahito
    Inoue, Makoto
    Mitomi, Hirofumi
    Tsuchida, Kosei
    Kaneko, Tetsuya
    Tamura, Yasuyuki
    Chikuda, Hirotaka
    JOURNAL OF ORTHOPAEDIC SURGERY, 2024, 32 (02)
  • [24] COMPARING REAL-WORLD RETENTION RATES IN A MATCHED COHORT OF RHEUMATOID ARTHRITIS PATIENTS WHO EITHER REMAINED ON THE ETANERCEPT ORIGINATOR OR SWITCHED TO A BIOSIMILAR
    Baganz, Lisa
    Strangfeld, Anja
    Herzer, Peter
    Krause, Andreas
    Tony, Hans-Peter
    Zink, Angela
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1136 - 1136
  • [25] Efficacy, safety, and adherence of tocilizumab therapy in elderly patients with rheumatoid arthritis: A real-world observational study
    Nakao, Yoshinobu
    Asanuma, Yu Funakubo
    Wada, Takuma Tsuzuki
    Matsuda, Mayumi
    Yazawa, Hiroaki
    Yoshida, Yoshihiro
    Todoriki, Akira
    Shintani, Ayumi
    Mimura, Toshihide
    EUROPEAN JOURNAL OF INFLAMMATION, 2021, 19
  • [26] SAFETY AND EFFICACY OF BIOLOGICS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS IN A REAL WORLD STUDY: USE OF INTRAVENOUS GOLIMUMAB AND INFLIXIMAB IN ADULTS WITH RHEUMATOID ARTHRITIS ≥65 YEARS OF AGE
    Schechtman, J.
    Broadwell, A.
    Kafka, S.
    Black, S.
    Xu, S.
    Langholff, W.
    Schwartzman, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 527 - 528
  • [27] SAFETY AND EFFICACY OF BIOLOGICS IN ELDERIY PATIENTS WITH RHEUMATOID ARTHRITIS IN A REAL WORLD STUDY: USE OF INTRAVENOUS GOLIMUMAB AND INFLIXIMAB IN ADULTS WITH RHEUMATOID ARTHRITIS '65 YEARS OF ACE
    Zazzetti, Federico
    Schechtman, Joy
    Broadwell, Aaron
    Kafka, Shelly
    Black, Shawn
    Xu, Stephen
    Langholff, Wayne
    Schwartzman, Sergio
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S109 - S110
  • [28] Retention on Adalimumab, Etanercept, Golimumab and Infliximab in Two Eras - Experience of Patients with Rheumatoid Arthritis from a Real-World Database RHUMADATA®
    Choquette, Denis
    Bessette, Louis
    Coupal, Louis
    Garces, Kirsten
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [29] Corticosteroid Use in Rheumatoid Arthritis Patients on Infliximab: Treatment Implications and Impact on Durability of Response Based on a Real-World Canadian Population
    Haraoui, Boulos
    Jovaisas, Algis
    Bensen, William
    Faraawi, Rafat
    Kelsall, John
    Dixit, Sanjay
    Rampakakis, Emmanouil
    Sampalis, John
    Nantel, Francois
    Otawa, Susan
    Lehman, Allen
    Shawi, May
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1444 - 1445
  • [30] Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study
    Curtis, Jeffrey R.
    Chakravarty, Soumya D.
    Black, Shawn
    Kafka, Shelly
    Xu, Stephen
    Langholff, Wayne
    Parenti, Dennis
    Greenspan, Andrew
    Schwartzman, Sergio
    RHEUMATOLOGY AND THERAPY, 2021, 8 (04) : 1551 - 1563
12345